Fairmount Healthcare Fund II L.P.

Director, 10% owner, Crescent Biopharma, Inc.; Director, 10% owner, Viridian Therapeutics, Inc.\DE

Bought, 12 months

$32.4M

Sold, 12 months

$0.0M

Companies

Latest trade

Jul 16, 2026

Companies

Crescent Biopharma, Inc.Director, 10% owner +$12.4M Viridian Therapeutics, Inc.\DEDirector, 10% owner +$20.0M

Trades

CBIO Bought 853,450 shares at $14.50 $12.4M Jul 16

VRDN Bought 1,176,470 shares at $17.00 $20.0M May 11

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.